Strides Pharma Science Share Price

₹ 1,036.90

-₹31.90 (-2.98%)
1D
Last updated 02 Nov, 2026, 15:55 IST
NSE: STAR
|
Pharmaceuticals

Strides Pharma Science Share Price Today

As of 3 Nov 2026, Strides Pharma Science share price is ₹1,036.90. The stock opened at ₹1,067.30, compared to its previous close of ₹1,068.80. During today's trading session, Strides Pharma Science share price moved in the range of ₹1,013.90 to ₹1,067.30, with an average price of ₹1,040.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹768.65 and a high of ₹1,260.90. On the performance front, Strides Pharma Science share price has increased by 0.01% over the last six months and is up 10.93% on a year-on-year basis.

₹1,013.90
2.98% down today
₹1,067.30
1D LOW
1D HIGH

Strides Pharma Science Stock Insights

Latest Earning
Op Profit TrendUp by 34.83% QoQ
Latest Earning
Net Profit TrendUp by 28.01% QoQ
Latest Earning
Revenue TrendUp by 8.33% YoY
Stock Performance
OutperformingBeat Nifty by 9.73 % in last 3 month
Shareholding Pattern
PromoterPromoter increased stake by 3.89%
Shareholding Pattern
DIIDII decreased stake by 22.26%
Shareholding Pattern
FIIFII decreased stake by 1.46%
Technical Indicators
MACD CrossThe MACD line crossed below the signal line on 1 Day interval.
Strides Pharma Science stock performance
Open₹1,067.30
High₹1,067.30
Low₹1,013.90
Prev. close₹1,068.80
Strides Pharma Science trading activity
Volume4,07,986
Average traded price₹1,032.40
Last traded time03:55:57 02 Nov
Last traded quantity10
Circuit
L
H
₹829.60
₹1,244.20
52-week
L
H
₹768.65
₹1,260.90
Mkt Cap Cr
9,854.65
P/E
15.47
P/B
2.88
ROA
8.51%
ROE
18.05%
ROCE
17.09%
Quick Ratio
0.68
EV/EBITDA
10.24

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Strides Pharma has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Strides Pharma appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Strides Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Strides Pharma Science Company Background

ISIN
INE939A01011
Sector Market Cap
₹ 9,854.65 Cr

Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.

Strides Pharma Science Financial Highlights

  • Revenue: Strides Pharma Science reported revenue of ₹5,009.39 crore in FY26 vs ₹4,624.06 crore in FY25. It showed an increase of 8.33% on a yearly basis.
  • Operating Profit: Strides Pharma Science reported an operating profit of ₹668.69 crore in FY26 vs ₹486.92 crore in FY25. It showed an increase of 37.33% on a year-on-year basis.
  • Net Profit: Strides Pharma Science reported a net profit of ₹574.52 crore in FY26 vs ₹3,597.51 crore in FY25. It showed a decrease of 84.03% on a yearly basis.

Strides Pharma Science Quarterly Result Highlights

  • Strides Pharma Science reported revenue of ₹1,270.30 crore in Jun 2026, compared with ₹1,331.60 crore in Mar 2026, representing a decrease of 4.60% on a quarter-on-quarter (QoQ) basis.
  • Strides Pharma Science reported an operating profit of ₹199.62 crore in Jun 2026, compared with ₹148.05 crore in Mar 2026, representing an increase of 34.83% on a quarter-on-quarter (QoQ) basis.
  • Strides Pharma Science reported a profit of ₹165.49 crore in Jun 2026, compared with ₹129.28 crore in Mar 2026, reflecting an increase of 28.01% on a QoQ basis.
  • The earnings per share (EPS) of Strides Pharma Science stood at ₹60.34 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
29.00%
FII
27.98%
Other DII
5.19%
Retail and other
27.51%
Mutual funds
10.31%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202529.52%
Mar 202628.68%
Jun 202628.39%
Sep 202627.98%

Strides Pharma Science Investment Returns

1 day
-2.98%
1 week
+0.37%
1 month
-4.42%
1 year
+10.93%
3 years
+313.19%
5 years
+283.75%

Strides Pharma Science Share Price History

Strides Pharma Science share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹1,067.30 / ₹1,036.90
-2.98%
30 Oct 26
₹1,050.00 / ₹1,068.80
-2.62%
29 Oct 26
₹1,087.40 / ₹1,097.50
+1.10%
28 Oct 26
₹1,093.30 / ₹1,085.60
-0.70%
Show more

Strides Pharma Science Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹4,858.68₹4,565.34₹3,890.13₹3,688.39
Other Income₹150.71₹58.72₹39.70₹90.33
Total Revenue₹5,009.40₹4,624.06₹3,929.83₹3,778.72
Total Expenses₹4,314.34₹4,203.63₹3,801.61₹3,762.60
Profit Before Tax₹668.69₹486.92-₹114.79-₹286.20
Tax₹94.17₹77.52₹29.11-₹55.30
Profit After Tax₹574.52₹409.41-₹143.90-₹230.90
EPS - Basic₹60.34₹390.55-₹7.76-₹22.49
EPS - Diluted₹60.34₹390.50-₹7.76-₹22.49

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹668.69₹3,675.03-₹62.72-₹267.63
Income before WC changes₹874.08₹790.91₹755.55₹414.56
Change in Assets-₹411.17-₹278.51₹69.79-₹355.52
Change in Liabilities₹310.72₹104.93-₹148.53-₹102.28
Change in WC-₹100.45-₹173.58-₹78.73-₹457.80
Cash flow from Operations₹702.52₹684.37₹701.07₹44.41
Cash flow from Investing-₹173.04-₹89.69-₹150.25₹302.47
Cash flow from Financing-₹453.41-₹642.58-₹693.32-₹213.92
Total Cash Flow₹76.07-₹47.90-₹142.51₹132.96
Cash (Start of the year)₹112.56₹161.02₹303.50₹170.73
Cash (End of the year)₹188.70₹112.56₹161.02₹303.50

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹3,313.89₹2,949.81₹2,870.76₹3,395.06
Current Assets₹3,613.34₹3,098.91₹2,969.00₹3,243.36
Total Assets₹6,927.23₹6,048.73₹5,839.76₹6,638.42
Current Liabilities₹2,895.49₹2,591.52₹2,879.26₹2,990.20
Net Current Asset₹717.85₹507.39₹89.74₹253.16
Non-Current Liabilities₹882.40₹870.74₹888.79₹1,475.34
Equity Capital₹3,149.34₹2,586.46₹2,071.71₹2,172.88
Total Equity & Liabilities₹6,927.23₹6,048.73₹5,839.76₹6,638.42

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹2,180.14₹2,139.42₹1,866.12₹1,854.50
Other Income₹123.06₹46.19₹58.71₹84.07
Total Revenue₹2,303.20₹2,185.61₹1,924.83₹1,938.56
Total Expenses₹2,100.10₹2,107.50₹1,942.40₹1,988.32
Profit Before Tax₹203.10₹78.08-₹22.93-₹64.76
Tax₹19.47₹18.93₹1.34-₹69.44
Profit After Tax₹183.64₹59.16-₹24.28₹4.68
EPS - Basic₹19.92₹313.68₹4.90₹0.52
EPS - Diluted₹19.92₹313.65₹4.89₹0.52

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹203.10₹2,905.14₹40.99-₹64.76
Income before WC changes₹248.66₹287.25₹291.89₹108.11
Change in Assets-₹166.78₹34.32-₹244.22₹20.63
Change in Liabilities₹197.26-₹22.61-₹115.39₹13.18
Change in WC₹30.48₹11.72-₹359.60₹33.81
Cash flow from Operations₹277.85₹421.48-₹14.01₹241.74
Cash flow from Investing-₹69.07-₹137.59-₹69.57-₹182.58
Cash flow from Financing-₹198.93-₹370.32₹93.34₹10.82
Total Cash Flow₹9.84-₹86.42₹9.77₹69.98
Cash (Start of the year)₹6.33₹92.75₹82.11₹12.12
Cash (End of the year)₹16.17₹6.33₹92.75₹82.11

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹3,022.13₹2,885.44₹3,490.70₹3,493.34
Current Assets₹2,373.59₹2,145.50₹2,411.18₹2,126.40
Total Assets₹5,395.72₹5,030.95₹5,901.87₹5,619.74
Current Liabilities₹1,840.07₹1,629.61₹2,085.14₹1,796.83
Net Current Asset₹533.52₹515.89₹326.04₹329.58
Non-Current Liabilities₹272.13₹208.60₹289.13₹367.86
Equity Capital₹3,283.52₹3,192.74₹3,527.60₹3,455.05
Total Equity & Liabilities₹5,395.72₹5,030.95₹5,901.87₹5,619.74
* All values are in INR Crore
Strides Pharma Science market depth
Bid quantityBid priceAsk priceAsk quantity
001036.973
0000
0000
0000
0000
Total bid quantity0
Total ask quantity73
Strides Pharma Science technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
47.49
Neutral
ATR (14)
44.09
Neutral
STOCH(9,6)
67.04
Neutral
STOCH RSI (14)
76.43
Neutral
ADX(9)
38.93
Bearish
UO(9)
60.57
Neutral
ROC(12)
-2.44
Bearish
WillR(14)
-32.96
Neutral
Period
Simple value
Exponential vaue
5D
1075.66
1071.96
10D
1049.13
1066.8
20D
1068.45
1076.13
50D
1094.13
1084.11
100D
1073.74
1069.78
Volume trend — traded volume by day
2 Nov4L
30 Oct26L
29 Oct2L
28 Oct3L
27 Oct7L
Average8L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Strides Pharma Science
Pharmaceuticals
Add Stock
Add Another

Strides Pharma Science Returns Calculator

Ex-date: 31 Jul 2026

Strides Pharma Science Latest News

2 months ago
Strides Pharma shares soar 10% as USFDA ends inspection at Bengaluru facility
Showing news item 1 of 1

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

Strides Pharma Science Share Price FAQs

Please be aware that Strides Pharma Science stock prices are subject to continuous fluctuations due to various factors.